Skip to content
value.today

Spectrum Antimicrobials, Inc.

🇺🇸 Petaluma, California, USAPharmaceuticalsFounded 2016

Formerly Avenlogics, Inc.

Total raised
$30 M
2 rounds on record
Latest round
$4 M
Jul 2022
First round on record
Mar 2020
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Spectrum Antimicrobials, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2022$4 MNo. 2$2 to $10 million

Spectrum Antimicrobials, Inc.: Raise no. 2, Jul 2022

Investors in this round

28 investors had bought by the notice of Sep 16, 2024: 28 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered; $0 M still to sell
Smallest investment taken
$10,000
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$802,395 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Nevada

People named in the notice

  • Hojabr Alimi · Executive Officer, Director, Promoter
  • Jerry Henry Stonemetz · Executive Officer
  • Sameer Harish · Executive Officer
  • William Henry Watson III · Executive Officer, Director, Promoter
  • David Henry Allie · Director
  • Kate Lewis · Director
  • Steven Henry Solferino · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Hojabr Alimi, Ceo. Source: SEC Form D, newest notice filed Sep 16, 2024. Read the notice at the SEC.

equity, debtSEC
Mar 2020$26 MNo. 1$10 to $50 million

Spectrum Antimicrobials, Inc.: Raise no. 1, Mar 2020

Investors in this round

247 investors had bought by the notice of Apr 1, 2026: 247 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$26 M of $35 M offered; $9 M still to sell
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$603,050
Finders' fees
none
Paid to its own people
$2,000,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Corporation, incorporated in Nevada

People named in the notice

  • Hojabr Alimi · Executive Officer, Director, Promoter
  • Jerry Henry Stonemetz · Executive Officer
  • William Henry Watson III · Executive Officer, Director, Promoter
  • David Henry Allie · Director
  • Kate Lewis · Director
  • Steven Henry Solferino · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Craft Capital Management LLC (CRD 171350) · broker-dealer Craft Capital Management LLC (CRD 171350) · Garden City, New YorkSold in all US states

Remarks in the notice

  • On fees: “7% cash sales commission and 7% warrant coverage to be paid to any broker/dealer engaged.”

Signed by Hojabr Alimi, Ceo. Source: SEC Form D and 5 amendments, newest notice filed Apr 1, 2026. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Spectrum Antimicrobials, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2026).

    SEC Form D · Apr 2026

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Sep 2024

That is all the official record says: Spectrum Antimicrobials, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Spectrum Antimicrobials, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 247 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Spectrum Antimicrobials, Inc.
NameRoleNamed in
Hojabr AlimiExecutive officerApr 2026
Jerry Henry StonemetzExecutive officerApr 2026
William Henry Watson IIIExecutive officerApr 2026
Sameer HarishExecutive officerSep 2024
Richard ZimmerExecutive officerApr 2021
Tchekanova BanafshehExecutive officerJun 2020
David Henry AllieDirectorApr 2026
Hojabr AlimiDirectorApr 2026
Kate LewisDirectorApr 2026
Steven Henry SolferinoDirectorApr 2026
William Henry Watson IIIDirectorApr 2026
Ronald Henry CarliDirectorApr 2021
Hojabr AlimiPromoterApr 2026
William Henry Watson IIIPromoterApr 2026